PubRank

Ganesh Raghu

Author PubWeight™ 137.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011 22.39
2 Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014 10.62
3 An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 6.82
4 Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007 6.71
5 Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012 6.51
6 An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med 2015 6.03
7 Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A 2007 5.95
8 Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 2008 5.82
9 An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012 5.37
10 The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005 4.25
11 Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008 3.97
12 Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011 3.85
13 BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007 3.49
14 BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011 3.23
15 Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 2010 3.05
16 Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004 2.97
17 Pulmonary fibrosis associated with aluminum trihydrate (Corian) dust. N Engl J Med 2014 2.88
18 Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011 2.54
19 Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One 2010 2.19
20 The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med 2009 2.18
21 Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med 2007 1.94
22 High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005 1.90
23 High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J Infect Dis 2001 1.85
24 Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2014 1.80
25 Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter. Chest 2008 1.65
26 Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest 2005 1.60
27 Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med 2014 1.54
28 Polymyositis associated with severe interstitial lung disease: remission after three doses of IV immunoglobulin. Chest 2011 1.47
29 The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax 2009 1.46
30 Lung allocation score for lung transplantation: impact on disease severity and survival. Chest 2007 1.33
31 Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 2010 1.30
32 Scleroderma lung disease. Eur Respir Rev 2013 1.04
33 Imaging of thoracic lymphatic diseases. AJR Am J Roentgenol 2009 0.92
34 Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects. Clin Chest Med 2004 0.89
35 Inherited interstitial lung disease. Clin Chest Med 2004 0.88
36 Idiopathic pulmonary fibrosis: increased survival with "gastroesophageal reflux therapy": fact or fallacy? Am J Respir Crit Care Med 2011 0.84
37 Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis. Eur Respir J 2013 0.83
38 Reduction in airway complications after lung transplantation with novel anastomotic technique. Ann Thorac Surg 2011 0.82
39 Development of Novel Agents for Idiopathic Pulmonary Fibrosis: Progress in Target Selection and Clinical Trial Design. Chest 2015 0.82
40 Improving the standard of care for patients with idiopathic pulmonary fibrosis requires participation in clinical trials. Chest 2009 0.81
41 A critical assessment of treatment options for idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2005 0.81
42 Bronchoalveolar cellular analysis in scleroderma lung disease: does Sutton's law hold? Am J Respir Crit Care Med 2008 0.79
43 Pirfenidone for IPF: pro/con debate; the 'con' viewpoint. Thorax 2013 0.79
44 Invasive pneumococcal infections in adult lung transplant recipients. Am J Transplant 2004 0.78
45 Acute constrictive pericarditis after lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 2008 0.75
46 More on pulmonary fibrosis associated with aluminum trihydrate (Corian) dust. N Engl J Med 2014 0.75
47 Reply: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2013 0.75
48 Reply: performing bronchoalveolar lavage as per the ATS guidelines 2012. Am J Respir Crit Care Med 2013 0.75
49 Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med 2013 0.75
50 Genetics of pulmonary fibrosis. Semin Respir Crit Care Med 2002 0.75
51 Challenges in diagnosing Sarcoidosis in tuberculosis endemic regions: Clinical scenario in India. Sarcoidosis Vasc Diffuse Lung Dis 2016 0.75